KLK3 and prostate carcinoma: • In the absence of a prostate cancer screening programme in the UK, the NHS should commission services that enable men at risk of prostate cancer to access PSA testing outside of primary care. These services must be high quality, have appropriate clinical oversight, and communicate effectively with the patient, primary care, and secondary care